Sponsor and CRO Finalists Announced for 2018 SCRS Eagle Award
Published: Sep 10, 2018
Ellicott City, MD, September 4, 2018 – Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 SCRS Eagle Award™, selected from companies nominated by SCRS members. The SCRS Eagle Award honors one sponsor and one CRO that exemplifies a site-focused approach to clinical trial management. Qualifying nominees were in the 75th percentile or higher of the total nominations submitted. The winning sponsor and CRO will be announced October 13th at the Global Site Solutions Summit in Boca Raton, FL.
Congratulations to the 2018 sponsor Eagle Award finalists: AstraZeneca, Eli Lilly & Co., Merck, Novo Nordisk, and Pfizer.
Congratulations to the 2018 CRO Eagle Award finalists: ICON, IQVIA, and Syneos Health (formerly INC Research/inVentiv Health).
“Every year, SCRS member sites are eager for the opportunity to nominate the sponsors and CROs that prioritize collaborative engagement to support site success,” said SCRS president Christine Pierre. “Congratulations to the Eagle Award finalists! We look forward to honoring each finalist at the Global Site Solutions Summit and celebrating the winning sponsor and CRO during the Summit Eagle Award Gala.”
Voting is now open to all clinical research site professionals, regardless of their membership status with SCRS. The opportunity to vote closes September 19th. Click here to vote!
Founded in 2012, SCRS is the global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, connectivity and mentorship. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.